It has been shown recently that the knockdown of RUNX2 in esophageal carcinoma cells significantly inhibits cell migration and invasion, suppresses tumor formation in vivo, and increases apoptosis [36]. This evidence concerns the gene RUNX2 and carcinoma of esophagus.